Global Gathering Dublin

Digital Therapeutics (DTx)
October 28 2021 - 10:00AM GMT
The Mansion House, Dawson St, Dublin 2
Apply to Attend

Precision Digital Therapeutics - the right DTx at the right time, for the right patient.

Places are extremely limited for both our Boston and Dublin events and are exclusively available to HealthXL members only. These events will not be streamed, recorded or shared - rather they are special member only events. Our events are collaborative in nature - there will be no keynote speakers, but rather a coming together of like-minded people to discuss & innovate the future of digital health.

HealthXL events comply with local and international recommendations and require all attendees to be fully vaccinated against Covid-19, and be able to provide proof of the same when required.

Agenda for the Event

We will explore precision digital therapeutics over two 90-minute sessions (Morning and Afternoon) with a break in-between for a networking lunch. In order to facilitate collaboration and shared insights with your peers, our event will be roundtable based (8 per table) with each table being afforded the opportunity to present their findings.

Morning Session - Selecting the Right DTx for a Patient (11:00am - 12:30pm)

Patients with a given condition are heterogenous where some drugs work better for different patients over others. The same will hold true for DTx solutions within a given condition. Understanding what DTx will work in a particular group of patients and how to make those decisions efficiently will be critical for DTx success in a broader population. What do we need to do now to realise this?

What data is required to differentiate between DTx solutions in a given condition and how should evidence be generated?

How can we modulate DTx dosing to suit different patient cohorts

What should CDSS look like for DTx solutions

Afternoon Session - How should Pharma and DTx developers collaborate to create a DTx ecosystem for different therapy areas? (1:30pm - 3:00pm)

Choosing the best combination of drug and DTx for a given patient will by its nature require brand-agnostic DTx solutions and the ability for patients to either change drugs and retain their DTx or vice versa. While this will involve many more stakeholders than just pharma and DTx developers, we want to start the discussion with this group.

How should DTx developer and pharma partnerships change to allow for brand-agnostic companion DTx solutions?

Who will invest in the required infrastructure to realise a condition-wide DTx ecosystem? What is the role for Pharma and what return would they expect?

How do we build a coalition of key stakeholders to create a condition-wide DTx ecosystem?

Apply to Attend
Apply to Attend

In good company

Francesca Wuttke
CEO and Founder, nen Health
Jochen Hurlebaus
Head of Innovation & IP, Roche Diagnostics
Robert Garber
Partner, 7wireVentures
Bill Taranto
President, Merck Global Health Innovation Fund
Steve Suentjens
Partner, Personal Health Solutions (PHS)
Lina Behrens
Managing Director, Flying Health
Ryan Sysko
CEO at Amalgam Rx, Inc
Brian Flatley
VP Consulting Services at S3 Connected Health
Chris Edwards
Chief Customer Experience, Success & Growth Officer at Conversa Health
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Matthias Essenpreis
Chief Technology Officer, Roche Diagnostics
Murray Brozinsky
Chief Executive Officer at Conversa Health
Philip Russmeyer
Founder & CEO, FITFILE
Tim Jurgens
Co-Founder & General Manager en SeedLink SL
Garret Coady
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Parisa Vatanka
Senior Director Corporate Alliances, American Pharmacists Association
Alexander Klein
Group Leader Digital Health, Roche
Ritesh Patel
Chief Digital Officer Health, Ogilvy Consulting
Apply to Attend

Apply to join HealthXL today to access our special 12-month Membership.

Our new exclusive and limited members package includes:

  • Engaging private roundtables: every week we host small groups of senior leaders
  • Problem-solving groups: working groups where we curate the groups and the outputs
  • In-person events: quarterly in-person meetings in the US / Europe / Asia
  • Access to insights from our members: daily curated news and regular insight analysis

Plus, an exclusive invite to our upcoming in-person events taking place in Boston and Dublin this October.

Do you want to be part of an exclusive community that will shape the future of Digital Health?

Get Stuff Done: We are doers. We solve problems by working together.

  • Our members engage and respond in a timely fashion
  • Our members support each other. If they commit to do something, they do their best to do it

Straight Talk: We say what we think and respect a diversity of ideas.

  • Our meetings and forums are safe spaces where chatham house rules apply
  • Our members do not pitch rather they build credibility from their contributions
  • Our members do not approach unsolicited or harass prospective customers who have clearly said no